[Endocrine therapy for localized or locally advanced prostate cancer].
The place of endocrine therapy, either alone or in combination with radiotherapy and surgery, remains highly controversial in the treatment of non-metastatic prostate cancer. The authors review the results of isolated endocrine therapy or associated with local therapy. At the present time, there are few arguments in favour of the use of endocrine therapy in the following situations: isolated treatment of localized or locally advanced cancer prior to radical prostatectomy, after radical prostatectomy. Current data suggest a benefit of endocrine therapy in combination with radiotherapy in patients with high-grade localized or locally advanced cancer.
Fontaine
Eric
E
Service d'Urologie, Hopital Ambroise Paré, Boulogne, France. eric.fontaine@apr-hop-paris.fr
Ruffion
Alain
A
Staerman
Frédéric
F
D000726:Androgen Antagonists / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery
D000726:Androgen Antagonists
Traitement hormonal du cancer de la prostate localisé ou localement avancé.